Saion Mukherjee · Nomura Securities
directWhat drove QoQ US improvement? Revlimid contribution?
I don't think the Revlimid contribution, quarter-on-quarter is significant, Sayan. I think the base business has also grown very impressively between quarter four and quarter one.
Saion Mukherjee · Nomura Securities
partialPipeline peptides and Abraxane bottleneck?
on Abraxane, we have received notification that, the only thing pending on the file is the site.
Rohan Vora · Purnartha Investment Advisers
directWhat is guided CapEx for FY24?
We said about 5% of the revenue, 4%-5%. Somewhere in the range of INR 1,000-INR 1,500 per annum is what you could take as the CapEx.
Rohan Vora · Purnartha Investment Advisers
directSplit between maintenance and growth CapEx?
You can take about 50/50, roughly, of maintenance and growth.
Prashant · Motilal Oswal Financial Services
directWhat drives US growth besides Revlimid?
I think it's a combination of various factors. Price compression is obviously lesser than before. At the same time, we are seeing... a rebalancing of the supply chain happening.
Prashant · Motilal Oswal Financial Services
partialWhat changed to raise EBITDA margin guidance to 23%?
We've had a good quarter, in this quarter one, so it gives us some confidence that we can take up that target of delivering 23% for the year.
Kunal Dhamesha · Macquarie
directAdvair amendment type and timeline?
No, it will be expected to be filed. We are still in the transfer stage right now. Yes, the chances are it will be a major amendment.
Damayanti Kerai · HSBC
directIs Advair opportunity beyond FY25?
No, not beyond FY 2025. Beyond this year, if Indore is not cleared, yes, but not beyond FY 2025.
Neha Manpuria · Bank of America
directIs US base of $210-215M before new launches?
Yes, broadly, Neha. Broadly, yes.
Krishnendu Saha · Quantum AMC
directHow many US launches contributed to Q1 growth?
over the last two years, our average will be sub 10 in each year. Of the seven or eight that we have launched in the last year, my guess is that about three to four of them have been very meaningful for us.
Kunal Randeria · Nuvama
directIs US growth due to higher primary vs secondary sales?
No, I don't think so, because our, you know, we do our regular audit processes for chargebacks, and inventory in trade is an input into that validation, and we haven't seen inventory holding going up.
Abdulkader Puranwala · ICICI Securities
directWhat is field force split chronic vs acute in India?
I think about 80%-- 75%-80% of our work, of our people are on the chronic side. 20% or so are on the acute side.